Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0W4NM
|
|||
| Former ID |
DIB013174
|
|||
| Drug Name |
Oltipraz
|
|||
| Synonyms |
CB-1400; Oltipraz (mucositis/radiation sickness/cancer); Oltipraz (mucositis/radiation sickness/cancer), Canopus Biopharma; Syntheticdithiolethione (oral, acute radiation syndrome/mucositis/cancer), Canopus
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 3 | [1] | |
| Company |
Canopus BioPharma Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H6N2S3
|
|||
| Canonical SMILES |
CC1=C(SSC1=S)C2=NC=CN=C2
|
|||
| InChI |
1S/C8H6N2S3/c1-5-7(12-13-8(5)11)6-4-9-2-3-10-6/h2-4H,1H3
|
|||
| InChIKey |
CKNAQFVBEHDJQV-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 64224-21-1
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:77319
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02068339) Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver Cirrhosis. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.